Lucinda Freeman

Lucinda Freeman

Auto-generated profile, based on publicly available information

Lucinda Freeman

Graduate School of Health, Faculty of Health, University of Technology Sydney, Sydney, Australia

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2024 in New England Journal of Medicine
Verified
Journal Article
Closed access
EKEdwin P. Kirk
Edwin P. Kirk
MDMartin Delatycki
Martin Delatycki
AAAlison D. Archibald
Alison D. Archibald
ETErin Tutty
Erin Tutty
JCJade Caruana
Jade Caruana
NLNigel George Laing
Nigel George Laing
Genomic sequencing technology allows for identification of reproductive couples with an increased chance, as compared with that in the general population, of having a child with an autosomal recessive or X-linked genetic condition. We investigated the feasibility, acceptability, and outcomes of a nationwide, couple-based genetic carrier screening program in Australia as part of the Mackenzie's Mission project. Health care providers offered screening to persons before pregnancy or early in pregnancy. The results obtained from testing at least 1281 genes were provided to the reproductive couples. We aimed to ascertain the psychosocial effects on participants, the acceptability of screening to all participants, and the reproductive choices of persons identified as having an increased chance of having a child with a condition for which we screened. Among 10,038 reproductive couples enrolled in the study, 9107 (90.7%) completed screening, and 175 (1.9%) were newly identified as having an increased chance of having a child with a genetic condition for which we screened. These conditions involved pathogenic variants in 90 different genes; 74.3% of the conditions were autosomal recessive. Three months after receiving the results, 76.6% of the couples with a newly identified increased chance had used or planned to use reproductive interventions to avoid having an affected child. Those newly identified as having an increased chance had greater anxiety than those with a low chance. The median level of decisional regret was low in all result groups, and 98.9% of participants perceived screening to be acceptable. Couple-based reproductive genetic carrier screening was largely acceptable to participants and was used to inform reproductive decision making. The delivery of screening to a diverse and geographically dispersed population was feasible. (Funded by the Medical Research Future Fund of the Australian government; ClinicalTrials.gov number, NCT04157595.).

Verified
Journal Article
Open access
PDF file
AAAlison D. Archibald
Alison D. Archibald
BMBelinda J. McClaren
Belinda J. McClaren
JCJade Caruana
Jade Caruana
ETErin Tutty
Erin Tutty
EKEmily A. King
Emily A. King
TTThe Mackenzie’s Mission Study Team
The Mackenzie’s Mission Study Team
Reproductive genetic carrier screening (RGCS) provides people with information about their chance of having children with autosomal recessive or X-linked genetic conditions, enabling informed reproductive decision-making. RGCS is recommended to be offered to all couples during preconception or in early pregnancy. However, cost and a lack of awareness may prevent access. To address this, the Australian Government funded Mackenzie’s Mission—the Australian Reproductive Genetic Carrier Screening Project. Mackenzie’s Mission aims to assess the acceptability and feasibility of an easily accessible RGCS program, provided free of charge to the participant. In study Phase 1, implementation needs were mapped, and key study elements were developed. In Phase 2, RGCS is being offered by healthcare providers educated by the study team. Reproductive couples who provide consent are screened for over 1200 genes associated with >750 serious, childhood-onset genetic conditions. Those with an increased chance result are provided comprehensive genetic counseling support. Reproductive couples, recruiting healthcare providers, and study team members are also invited to complete surveys and/or interviews. In Phase 3, a mixed-methods analysis will be undertaken to assess the program outcomes, psychosocial implications and implementation considerations alongside an ongoing bioethical analysis and a health economic evaluation. Findings will inform the implementation of an ethically robust RGCS program.

6 February 2023 in Bioethics
Verified
Journal Article
Open access
LDLisa Dive
Lisa Dive
AAAlison D. Archibald
Alison D. Archibald
LFLucinda Freeman
Lucinda Freeman
ANAinsley Newson
Ainsley Newson
Reproductive genetic carrier screening provides information about people's chance of having children with certain genetic conditions. Severity of genetic conditions is an important criterion for their inclusion in carrier screening programmes. However, the concept of severity is conceptually complex and underspecified. We analyse why severity is an important concept in carrier screening and for reproductive decision‐making and show that assessments of severity can also have normative societal implications. While some genetic conditions are unambiguously associated with a high degree of suffering, there are many factors that contribute to how severe a condition is perceived to be, and perspectives will vary. Attempts to classify genetic conditions according to their severity tend to prioritise biomedical information at the expense of incorporating qualitative aspects of the impact of genetic conditions on people's lives. Further complexity arises because some genotypes can present with variable phenotypes and because some conditions are not always experienced in the same way by all people who have them. To acknowledge this complexity, we argue that an understanding of severity needs to distinguish between the severity of a genetic condition—requiring a generalised approach for purposes of policy development and programme design—and the severity of an instance of a genetic condition in a particular person. Families making reproductive decisions also require access to diverse experiences of the qualitative aspects of living with genetic conditions. As a result, reproductive carrier screening programmes must recognise and respond to the complexity inherent in determining the severity of genetic conditions.

22 August 2025 in European Journal of Human Genetics
Verified
Journal Article
Closed access
PDF file
MMMichael P. Mackley
Michael P. Mackley
PAPankaj Agrawal
Pankaj Agrawal
SASara S. Ali
Sara S. Ali
AAAlison D. Archibald
Alison D. Archibald
BDBelinda Dawson-McClaren
Belinda Dawson-McClaren
AMAlisdair McNeill
Alisdair McNeill

3 June 2022 in Genetics in Medicine
Verified
Journal Article
Closed access
LFLucinda Freeman
Lucinda Freeman
SRSarah Righetti
Sarah Righetti
MDMartin B. Delatycki
Martin B. Delatycki
JSJackie Leach Scully
Jackie Leach Scully
EKEdwin P. Kirk
Edwin P. Kirk

2 August 2023 in Journal of Genetic Counseling
Verified
Journal Article
Open access
LFLucinda Freeman
Lucinda Freeman
LBLisa Bristowe
Lisa Bristowe
EKEdwin P. Kirk
Edwin P. Kirk
MDMartin B. Delatycki
Martin B. Delatycki
JSJackie Leach Scully
Jackie Leach Scully
Many commercial reproductive genetic carrier screening (RGCS) panels include genes associated with non‐syndromic hearing loss (NSHL), however little is known about the general acceptability of their inclusion. Although some couples wish to avoid having a deaf child, there are effective interventions and supports available for deafness, and no consensus on whether it is appropriate to reproductively screen NSHL genes. This study explored views of people with personal experience of deafness regarding carrier screening for genes associated with NSHL. We interviewed 27 participants; 14 who identified as deaf and 13 hearing parents of a deaf child. Thematic analysis was undertaken on transcripts of interviews. The findings reveal the complexity of attitudes within these groups. Some vacillated between the wish to support prospective parents' reproductive autonomy and concerns about potential harms, especially the expression of negative messages about deafness and the potential loss of acceptance in society. While some participants felt carrier screening could help prospective parents to prepare for a deaf child, there was little support for reproductive screening and termination of pregnancy. Participants emphasized the need for accurate information about the lived experience of deafness. The majority felt deafness is not as severe as other conditions included in RGCS, and most do not consider deafness as a disability. People with personal experience of deafness have diverse attitudes towards RGCS for deafness informed by their own identify and experience, and many have concerns about how it should be discussed and implemented in a population wide RGCS program.